Fig. 5.
Anti‐candida activity. Row A, Bi2 O3 nano‐needles; row B, bulk Bi2 O3 powder; row C, itraconazole; row D, 10% HNO3; column 11, positive control; column 12, sterility control
Anti‐candida activity. Row A, Bi2 O3 nano‐needles; row B, bulk Bi2 O3 powder; row C, itraconazole; row D, 10% HNO3; column 11, positive control; column 12, sterility control